News

We will be showcasing our Osteochondral Platform at ICRS 2023, a major event in the field of cartilaginous tissue research and joint preservation taking place in Sitges from September 9th to 12th. Join the In Vitro Models session on the 10th at 13:15 in Tramuntana 3 to learn more about our innovative technologies and to connect with our team.

We will showcase our Cardiac BioSimulator at the ESC Amsterdam Conference, allowing attendees to experience realistic cardiac training, including echo techniques and 3D skills with Philips, while also supporting GE HealthCare with an interactive session on Transesophageal Echocardiography (TEE) assessment.

The time has come to say goodbye to Davy and Alicia!

We're proud that our work has contributed to a new publication! It reports the development of the MarioHeart in-vitro model by researchers of the Eindhoven University of Technology and the University Medical Center Utrecht, in collaboration with LifeTec Group, which enables the testing of thrombogenicity of mechanical heart valve prostheses and potential anticoagulant therapies through its unique design and realistic flow simulation.

We are delighted to share that LifeTec Group is to be part of the NXTGEN HIGHTECH program. By participating in this initiative, we will unite with esteemed industry pioneers and renowned educational institutions to address pressing societal challenges and position The Netherlands at the forefront of the global high-tech industry.

Our Cardiac BioSimulator has once again played a crucial role in a recent publication. This publication outlines an ex vivo cardiac study conducted to examine the potential of intravalvular impedance (IVI) measurements in a sensorized biological heart valve prosthesis.

We had a great training and team building day together with Rachael Raskovich from Resolution Medical.

We are thrilled to announce that João, a talented and passionate researcher, has joined our team at LifeTec Group! Discover more about his incredible journey and how he has become a very valuable asset to our organization.

As part of the RegMed XB project, LifeTec Group is working with the University Medical Center in Utrecht to develop regenerative technologies for repairing failing human hearts.